Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden

被引：1
|
作者：
Lahteenvuo, M. [1 ]
Batalla, A. [2 ]
Luykx, J. [3 ]
Mittendorfer-Rutz, E. [4 ]
Tanskanen, A. [4 ]
Tiihonen, J. [4 ]
Taipale, H. [4 ]
机构：
[1] Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland
[2] Univ Med Ctr Utrecht, Psychiat, Utrecht, Netherlands
[3] Univ Utrecht, Dept Psychiat, Utrecht, Netherlands
[4] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
来源：
EUROPEAN PSYCHIATRY | 2021年 / 64卷
关键词：
schizophrenia; substance abuse disorders; epidemiology; dual diagnosis;
D O I：
10.1192/j.eurpsy.2021.636
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0211
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [1] Morbidity and mortality in schizophrenia with comorbid substance use disorders
    Lahteenvuo, Markku
    Batalla, Albert
    Luykx, Jurjen J.
    Mittendorfer-Rutz, Ellenor
    Tanskanen, Antti
    Tiihonen, Jari
    Taipale, Heidi
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 42 - 49
  • [2] Treating comorbid substance use disorders in schizophrenia
    Lubman, Dan I.
    King, Joel A.
    Castle, David J.
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2010, 22 (02) : 191 - 201
  • [3] Cancer care and mortality in patients with schizophrenia, substance use and mood disorders in Finland
    Manderbacka, K.
    Arffman, M.
    Suvisaari, J.
    Ahlgren-Rimpilainen, A.
    Lumme, S.
    Keskimaki, I.
    Pukkala, E.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27 : 307 - 307
  • [4] CANCER CARE AND MORTALITY IN PATIENTS WITH SCHIZOPHRENIA, SUBSTANCE USE, AND MOOD DISORDERS IN FINLAND
    Suvisaari, Jaana
    Manderbacka, Kristiina
    Keskimaki, Ilmo
    Arffman, Martti
    Ahlgren-Rimpilainen, Aulikki
    Pukkala, Eero
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 : S79 - S79
  • [5] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [6] Treatment for Outpatients with Comorbid Schizophrenia and Substance Use Disorders: A Review
    De Witte, Nele A. J.
    Crunelle, Cleo L.
    Sabbe, Bernard
    Moggi, Franz
    Dom, Geert
    [J]. EUROPEAN ADDICTION RESEARCH, 2014, 20 (03) : 105 - 114
  • [7] Comorbid substance use disorders in schizophrenia: A latent class approach
    Kerner, Befit
    [J]. PSYCHIATRY RESEARCH, 2015, 225 (03) : 395 - 401
  • [8] THE CONTRIBUTION OF SUBSTANCE USE DISORDERS TO MORTALITY IN SCHIZOPHRENIA
    Hjorthoj, Carsten Rygaard
    Ostergaard, M.
    Benros, M. E.
    Toftdahl, N. G.
    Erlangsen, A.
    Andersen, J. T.
    Nordentoft, M.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S142 - S142
  • [9] Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
    Prat, Gemma
    Marquez-Arrico, Julia E.
    Rio-Martinez, Laura
    Navarro, Jose Francisco
    Adan, Ana
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110
  • [10] Mortality attributable to alcohol and substance use disorders in people with schizophrenia
    Hjorthoj, Carsten Rygaard
    Ostergaard, Marie Louise Drivsholm
    Toftdahl, Nanna Gilliam
    Erlangsen, Annette
    Benros, Michael Eriksen
    Andersen, Jon Traerup
    Nordentoft, Merete
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 14 - 14
12345